Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 1 to 6 of 6 matches

Category 6 - PATHOLOGY SERVICES

Cystic fibrosis gene testing

Category 6 - PATHOLOGY SERVICES

73345

73345 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
01-Jul-2018
Schedule Fee Updated:
01-Jul-2018

Group
P7 - Genetics

Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of investigating, making or excluding a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73347, 73348, or 73349 applies.

The patient must have clinical or laboratory findings suggesting there is a high probability suggestive of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder.



Fee: $500.00 Benefit: 75% = $375.00 85% = $425.00

(See para PN.7.3, PN.7.16 of explanatory notes to this Category)

Category 6 - PATHOLOGY SERVICES

73347

73347 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
01-Jul-2018
Schedule Fee Updated:
01-Jul-2018

Group
P7 - Genetics

Testing of a prospective parent for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the risk of their fetus having pathogenic cystic fibrosis transmembrane conductance regulator variants. This is indicated when the fetus has ultrasonic evidence of echogenic gut when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73348, or 73349 applies.



Fee: $500.00 Benefit: 75% = $375.00 85% = $425.00

(See para PN.7.3, PN.7.16 of explanatory notes to this Category)

Category 6 - PATHOLOGY SERVICES

73348

73348 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
01-Jan-2020
Schedule Fee Updated:
01-Jul-2018

Group
P7 - Genetics

Testing of a patient with a laboratory-established family history of pathogenic cystic fibrosis transmembrane conductance regulator variants, for the purpose of determining whether the patient is an asymptomatic genetic carrier of the pathogenic cystic fibrosis transmembrane conductance regulator variants that have been laboratory established in the family history, not being a service associated with a service to which item 73345, 73347, or 73349 applies.

The patient must have a positive family history, confirmed by laboratory findings of pathogenic cystic fibrosis transmembrane conductance regulator variants, with a personal risk of being a heterozygous genetic carrier of at least 6%. (This includes family relatedness of: parents, children, full-siblings, half-siblings, grand-parents, grandchildren, aunts, uncles, first cousins, and first cousins once-removed, but excludes relatedness of second cousins or more distant relationships).



Fee: $250.00 Benefit: 75% = $187.50 85% = $212.50

(See para PN.7.3, PN.7.16 of explanatory notes to this Category)

Category 6 - PATHOLOGY SERVICES

73349

73349 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
01-Jul-2018
Schedule Fee Updated:
01-Jul-2018

Group
P7 - Genetics

Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the reproductive risk of the patient with their reproductive partner because their reproductive partner is already known to have pathogenic cystic fibrosis transmembrane conductance regulator variants requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73347, or 73348 applies.



Fee: $500.00 Benefit: 75% = $375.00 85% = $425.00

(See para PN.7.3, PN.7.16 of explanatory notes to this Category)

Category 6 - PATHOLOGY SERVICES

73451

73451 - Additional Information

Item Start Date:
01-Nov-2023
Description Updated:
01-Nov-2024
Schedule Fee Updated:
01-Nov-2023

Group
P7 - Genetics

Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine:

(a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene—reproductive risk of cystic fibrosis;

(b) for the survival motor neuron 1 (SMN1) gene—reproductive risk of spinal muscular atrophy;

(c) for the fragile X mental retardation 1 (FMR1) gene—reproductive risk of fragile X syndrome;

(other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies)

One test per lifetime



Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

(See para PN.7.16 of explanatory notes to this Category)

Results 1 to 6 of 6 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change